FDA Investigator: Mayar M. Mussa
- Mayar M. Mussa first started conducting FDA inspections in 2023, with the last inspection in 2024. Over that time, Mayar M. Mussa has conducted 16 inspections at 15 companies across 15 sites.
Get Mayar Mussa's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Novartis Pharmaceuticals, East Hanover | August 2023
Available Now - $199
Mayar M. Mussa
Human Drugs Form 483
FDA 483 Wockhardt USA LLC, Parsippany | 2024
Out-of-stock
Mayar M. Mussa
Human Drugs Form 483
FDA 483 Strides Pharma Inc., East Brunswick | 2024
Out-of-stock
Mayar M. Mussa
Human Drugs Form 483
FDA 483 Quagen Pharmacuticals, LLC, West Caldwell | 2023
Out-of-stock
Mayar M. Mussa
Human Drugs Form 483
FDA 483 Teva Pharmaceuticals USA Inc, Parsippany | 2023
Out-of-stock
Mayar M. Mussa
Human Drugs Form 483
FDA 483 Vinay Sikand, M.D., Toms River | 2023
Out-of-stock
Mayar M. Mussa
Human Drugs Form 483